Research has demonstrated that the inhibition of NLRP3 inflammasome activation can mitigate the inflammatory response and the expression of kidney injury markers such as neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) in mice with lipopolysaccharide-induced acute kidney injury (77). This evidence concerns the gene NLRP3 and acute kidney injury.